| || Home | || Site Map | || Appointments | || Patient Support |
Alzheimer's Disease and Neurodegenerative Conditions
[Original
article and subscriptions available.]
This is a service of Rachel's Environment
and Health News: Rachel Carson, the famous scientist and writer, published
Silent Spring in 1962, warning that toxic industrial chemicals and pesticides
would cause irreparable harm to the environment and to human health. In 1986,
we began publishing Rachel's Environment & Health News, which we
named in honor of Rachel Carson. Rachel's provides timely information on toxic
substances and other environmental hazards. The newsletter covers many
technical issues, such as the toxicity of dioxin, incinerator emissions,
rising cancer rates, and the intricacies of risk assessment, but it is written
in plain language that anyone can understand. Much of the information covered
in Rachel's never appears in the
mainstream media and can only be found in medical and scientific journals that
most people never see. Furthermore, Rachel's tries
to put environmental problems into a political context of money and power, so
that people can see how all our problems - and all our local fights -- are
connected. To address these "big picture" concerns, we discuss
issues such as the influx of money into our elections, the enormous influence
of multinational corporations, and other distortions of our democracy.
ORIGINS OF DEMENTIA, PT. 1
by Sandra Steingraber, Ph.D.*
Here is a sign of our times: within the publishing world, a new nonfiction
subgenre has emerged -- the Alzheimer's memoir. Among the first was Elegy for
Iris, written by English literary critic John Bayley about his wife, the
novelist Iris Murdoch. In both the book and the movie based on it, we see the
famously brilliant Murdoch descend into a mental state in which, no longer
able to dress or speak, she desires only to watch the famously simple
children's show, Teletubbies. More recent are The House on Beartown Road: A
Memoir of Learning and Forgetting by journalist Elizabeth Cohen, which was
excerpted in People magazine, and The Story of My Father by best-selling
novelist Sue Miller, which was profiled in Reader's Digest.[1]
And these include only the books in which the subject of the story is a former
college professor. There are many, many others.
My own father is a former college professor, and he suffers from dementia. He
now lives in a nursing home. This is hardly an unconventional situation --
half of all nursing home residents in the United States are demented[2] -- but
the decision to place him there was an extraordinary one for our family. After
fifty years of marriage, my father wanted to live out his days with my mother
in the house that he had built for them both when she was a young bride; my
mother was devoted to caring for him there, no matter what it took. And for
several years after his diagnosis she did.
But then Dad became "delusional and combative," in the language of
neurology. "Delusional" meant he came to believe my mother was
having an affair. He grew suspicious when the phone rang. He followed her to
the mailbox, shouting accusations. He prowled the house at night looking for
the other man. He stood over her while she slept. "Combative" meant
that he began to relive his experiences in Italy during World War II. It was a
dangerous combination.
And so, my retired college professor father -- the man who introduced me to
calculus and Rachel Carson, who planted an organic garden every spring, who
took up the piano in his 40s, who loved to embroider, bake bread, and make
candles, who had seat belts installed in the family car before they were
standard-issue -- is now institutionalized in a facility from which he
regularly attempts to escape and whose staff he periodically attempts to
assault. He has quite literally become an imprisoned combatant, which was his
biggest fear when, sixty years ago as a teenage soldier, he sailed into the
Mediterranean on a warship.
In the Alzheimer's wing of the nursing home where he lives a detailed
description of each resident is posted on the door to their room. It's a way
of helping the patients remember where their beds are located. These
biographies also remind my mother, my sister, and me that Dad is part of a
much bigger tribe. The dementia-sufferers there include former teachers,
former farmers, former entrepreneurs, former church ministers, former world
travelers, former ballroom dancers. Each has a life history, a family, an
identity.
And this small, rural nursing home is itself part of a larger collective
story. In the United States, about 4.5 million people suffer from Alzheimer's
disease, and another 1.5 million from other forms of dementia. Because the
risk of developing a dementing illness rises sharply with age (ten percent of
those over 65 years old are afflicted with Alzheimer's, while 40 percent of
those over 85 are) and because the population itself is aging rapidly (the
first baby boomers turn 65 in 2011), we are standing on the cusp of a
slow-motion epidemic.[3,4] A disease for which there is no cure, Alzheimer's
has already risen from the 12th leading cause of death to the 8th.[5] By the
year 2050, 10-15 million Americans are projected to have Alzheimer's -- more
than double the number we have now.[3,4]
The economic implications of these statistics are equally sobering. (And, as
an accounting professor, my father would have found them compelling.)
Alzheimer's patients live, on average, eight years after diagnosis. During
this time, they require, on average, $213,000 in medical care. This makes
Alzheimer's the third most expensive disease in the United States. (Cancer and
heart disease still take the top two slots.)[3] Yes, someone has done the
math: the current economic burden of Alzheimer's, in medical treatment costs
alone, is about $100 billion each year.[3] One researcher has estimated that
annual costs could rise to $700 billion by 2050.[4] These figures do not
include the one-third of neurodegenerative dementias that are non-Alzheimer's
in origin. The prevalence of Lewy-body dementia (which is the second most
common form of dementia) and Parkinson's disease (which leads to dementia in
one third of all cases) is also expected to increase sharply as the population
ages.[6,7]
All these diseases are officially classified as "idiopathic disorders of
unknown pathogenesis,"[7] which is another way of saying that no one
knows what causes them. Thus, in addition to presenting overwhelming personal
challenges to those afflicted and to their caregivers, neurodegenerative
dementia brings with it four other miserable characteristics: it has no known
cause; it has no known cure; it is becoming increasingly common; and it costs
considerably more than an average home mortgage to care for each person
diagnosed.
Clearly, then, addressing the question of dementia's causality should be a
national priority. Some medical researchers are indeed working feverishly to
understand the genesis of dementia, and, while their efforts have not yet
taken on the coordinated urgency that has characterized, say, the atomic bomb
program in the 1940s or the space program in the 1960s, there are signs of an
emerging new framework for inquiry.
In May 2003, the Mount Sinai School Center for Children's Health and the
Environment organized an important conference at the New York Academy of
Medicine entitled "Early Environmental Origins of Neurodegenerative
Disease in Later Life."[8] In Rachel's #777, we will take a close look at
the evidence for an environmental connection to Alzheimer's and Parkinson's
disease. Here we will examine the conceptual rationale for pursuing early-life
environmental links to late-life dementias, as presented at this
ground-breaking conference.
The chain of logic goes as follows. First, inheritance alone appears to play
little direct role in the risk of developing dementia. (Heredity explains only
five percent of Parkinson's disease, for example.[9]) This means we need to
look toward the environment, possibly in concert with genetics and lifestyle
factors, to understand dementia's root causes.
Second, many neurodegenerative diseases are thought to arise through a series
of stages that require many years or even many decades to progress. The
cascade of neuronal changes leading to Alzheimer's may already be evident in
one's 20s or 30s.[10] This means toxic exposures early in life -- even
prenatal exposures -- may be more relevant to late-life dementias than
equivalent exposures encountered later.[5]
Third, many cognitive disorders known to be caused by exposure to toxic
chemicals have decades-long latent effects. Dupont workers exposed to high
levels of lead on the job showed more rapid cognitive declines during their
retirements than coworkers exposed to lower lead levels, even though neither
group had been exposed to any lead for almost twenty years. Similar findings
come from South Korea.[11]
Fourth, animal studies show that early-life exposures to certain neurotoxic
chemicals can create subtle but permanent changes in the brain that produce no
functional deficits until the effects of these "silent toxicities"
are unmasked by later challenges.[12] This means early-life exposures to
neurotoxic chemicals can enhance susceptibility to late-life exposures.
Fifth, neurotoxic chemicals, in the form of pesticides, persistent
organochlorines, and heavy metals, are widely distributed in the U.S.
environment.[5]
Sixth, human studies of non-dementing illnesses show that certain factors
encountered early in life can predispose an individual to the development of
disease in their elder years. For example, studies in England show that babies
born small because they were denied adequate nutrition in the womb develop
into adults who are, in advanced age, at higher risk of hypertension, stroke,
diabetes, and breast or prostate cancer. The results of these studies suggest
that infants are "programmed" by environmental insults that take
place at a critical period of development in ways that have lifelong
consequences. This idea is known as the Barker Hypothesis.[13] In Rachel's
#777, we shall explore the relevance of the Barker Hypothesis for Alzheimer's
and Parkinson's Disease. ==============
*Sandra Steingraber is a biologist and author (see Rachel's #565). She is
currently a Distinguished Visiting Scholar in the Interdisciplinary Studies
Program at Ithaca College in Ithaca, New York.
Unless otherwise noted, all citations refer to presentations made at the Mt.
Sinai School of Medicine conference, "Early Environmental Origins of
Neurodegenerative Disease in Later Life: Research and Risk Assessment"
(New York Academy of Medicine, May 16, 2003). Conference proceedings are
currently in preparation for publication.
[1] J. Bayley, Elegy for Irish (New York: St. Martins Press, 1999); E. Cohen,
The House on Beartown Road: A Memoir of Learning and Forgetting (New York:
Random House, 2003); S. Miller, Story of My Father (New York: Knopf, 2003).
[2] Robert Butler, M.D., President and CEO, International Longevity Center,
"Early Determinants of Disease in the Elderly."
[3] M. Saleem Ismail, "Trials, Tribulations and Triumphs in Alzheimer's
Disease: Where Are We Now and Where Are We Going?" presentation at the
Ithaca College Gerontology Institute conference, "Meeting the Challenge
of Dementia," May 29, 2003.
[4] D. Shenk, The Forgetting -- Alzheimer's: Portrait of an Epidemic (New
York: Doubleday, 2001), pg. 5.
[5] Introduction to conference proceedings, pgs. 1-2.
[6] G.B. Wilks, "Supportive Treatment of Lewy Body Dementia,"
Patient Care Vol. 34 (2002), pgs. 85-90.
[7] R.L Nussbaum and C.E. Ellis, "Alzheimer's Disease and Parkinson's
Disease," New England Journal of Medicine Vol. 348 (2003), pgs. 1356-64.
[8] Co-organizers of the conference were the International Longevity Center,
the Bachmann-Strauss Dystonia and Parkinson Foundation, and the Children's
Environmental Health Network.
[9] C. Warren Olanow, M.D., Mt. Sinai School of Medicine, "New Research
in Parkinson's Disease."
[10] John Morrison, Ph.D., Mt. Sinai School of Medicine, "Neurobiology of
Aging and Dementia,"
[11] Andrew Todd, Ph.D., Mt. Sinai School of Medicine, "Lead and Loss of
Cognition."
[12] Deborah Cory-Slechta, Ph.D., University of Rochester, "Animal Models
of Parkinson's Disease."
[13] C. Osmond and D.J.P. Barker, "Fetal, Infant, and Childhood Growth
Are Predictors of Coronary Heart Disease, Diabetes, and Hypertension in Adult
Men and Women," Environmental Health Perspectives Vol. 108 Supplement 3
(2000), pgs. 545-553.
###############################################################
#
NOTICE In accordance with Title 17 U.S.C. Section 107 this material is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. Some of this material may be copyrighted by others. We believe we are making "fair use" of the material under Title 17, but if you choose to use it for your own purposes, you will need to consider "fair use" in your own case and perhaps seek reprint permission from the copyright owner. Environmental Research Foundation provides this electronic version of RACHEL'S ENVIRONMENT & HEALTH NEWS free of charge even though it costs the organization considerable time and money to produce it. We would like to continue to provide this service free. You could help by making a tax-deductible contribution (anything you can afford, whether $5.00 or $500.00). Please send your tax-deductible contribution to: Environmental Research Foundation, P.O. Box 160, New Brunswick, NJ 08903-0160. Please do not send credit card information via E-mail. For further information about making tax-deductible contributions to E.R.F. by credit card please phone us toll free at 1-888-2RACHEL, or at (732) 828-9995, or fax us at (732) 791-4603. --Peter Montague, Editor